S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
Retirees Face “Income Destruction” (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
3 Stable Growth Stocks for Bumpy Times
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
Retirees Face “Income Destruction” (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
3 Stable Growth Stocks for Bumpy Times
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
Retirees Face “Income Destruction” (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
3 Stable Growth Stocks for Bumpy Times
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
Retirees Face “Income Destruction” (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
The 2 Dow Stocks with Decade-Long Win Streaks on the Line
3 Stable Growth Stocks for Bumpy Times
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Large And Small Oil-And-Gas Stocks See Post-Earnings Bounce
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
NYSE:RMED

Ra Medical Systems - RMED Stock Forecast, Price & News

$0.18
+0.01 (+5.85%)
(As of 08/11/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.18
$0.19
50-Day Range
$0.16
$0.43
52-Week Range
$0.15
$3.65
Volume
3.17 million shs
Average Volume
4.74 million shs
Market Capitalization
$5.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00

Ra Medical Systems MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
6,533.5% Upside
$12.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.72) to ($0.40) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.76 out of 5 stars

RMED stock logo

About Ra Medical Systems (NYSE:RMED) Stock

Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Ra Medical Systems Trading Up 4.0 %

Shares of NYSE:RMED traded up $0.01 during trading on Thursday, reaching $0.18. The stock had a trading volume of 3,167,502 shares, compared to its average volume of 4,741,290. Ra Medical Systems has a one year low of $0.15 and a one year high of $3.65. The company has a market capitalization of $5.84 million, a P/E ratio of -0.05 and a beta of 1.08. The firm's 50-day simple moving average is $0.28 and its 200 day simple moving average is $0.37.

Ra Medical Systems (NYSE:RMED - Get Rating) last released its quarterly earnings results on Monday, May 16th. The company reported ($0.27) earnings per share for the quarter. Ra Medical Systems had a negative net margin of 2,278.22% and a negative return on equity of 152.46%. The firm had revenue of $0.01 million during the quarter. Equities research analysts forecast that Ra Medical Systems will post -0.72 earnings per share for the current fiscal year.

Receive RMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

RMED Stock News Headlines

Ra Medical Systems Up 39%
RMED Ra Medical Systems, Inc.
Ra Medical Systems Misses Q1 EPS by 10c
Ra Medical plunges 13% after wider Q4 loss
Ra Medical Systems CEO Issues Letter to Stockholders
See More Headlines
Receive RMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

RMED Company Calendar

Last Earnings
5/16/2022
Today
8/11/2022
Next Earnings (Estimated)
8/15/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
58
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$12.00
High Stock Price Forecast
$12.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+6,533.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-25,070,000.00
Net Margins
-2,278.22%
Pretax Margin
-2,526.85%

Debt

Sales & Book Value

Annual Sales
$20,000.00
Book Value
$1.95 per share

Miscellaneous

Free Float
31,987,000
Market Cap
$5.84 million
Optionable
Not Optionable
Beta
1.08














RMED Stock - Frequently Asked Questions

Should I buy or sell Ra Medical Systems stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ra Medical Systems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RMED shares.
View RMED analyst ratings
or view top-rated stocks.

What is Ra Medical Systems' stock price forecast for 2022?

1 brokers have issued 12 month price objectives for Ra Medical Systems' shares. Their RMED share price forecasts range from $12.00 to $12.00. On average, they anticipate the company's share price to reach $12.00 in the next twelve months. This suggests a possible upside of 6,493.4% from the stock's current price.
View analysts price targets for RMED
or view top-rated stocks among Wall Street analysts.

How have RMED shares performed in 2022?

Ra Medical Systems' stock was trading at $1.56 at the beginning of 2022. Since then, RMED shares have decreased by 88.3% and is now trading at $0.1820.
View the best growth stocks for 2022 here
.

When is Ra Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 15th 2022.
View our RMED earnings forecast
.

How were Ra Medical Systems' earnings last quarter?

Ra Medical Systems, Inc. (NYSE:RMED) released its quarterly earnings results on Monday, May, 16th. The company reported ($0.27) EPS for the quarter. The firm had revenue of $0.01 million for the quarter. Ra Medical Systems had a negative trailing twelve-month return on equity of 152.46% and a negative net margin of 2,278.22%.

When did Ra Medical Systems' stock split?

Ra Medical Systems shares reverse split on the morning of Tuesday, November 17th 2020. The 1-25 reverse split was announced on Monday, November 16th 2020. The number of shares owned by shareholders was adjusted after the closing bell on Monday, November 16th 2020. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What other stocks do shareholders of Ra Medical Systems own?

When did Ra Medical Systems IPO?

(RMED) raised $50 million in an IPO on Thursday, September 27th 2018. The company issued 3,300,000 shares at a price of $14.00-$16.00 per share. Piper Jaffray and Cantor acted as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers.

What is Ra Medical Systems' stock symbol?

Ra Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMED."

How do I buy shares of Ra Medical Systems?

Shares of RMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ra Medical Systems' stock price today?

One share of RMED stock can currently be purchased for approximately $0.18.

How much money does Ra Medical Systems make?

Ra Medical Systems (NYSE:RMED) has a market capitalization of $5.88 million and generates $20,000.00 in revenue each year. The company earns $-25,070,000.00 in net income (profit) each year or ($3.45) on an earnings per share basis.

How can I contact Ra Medical Systems?

Ra Medical Systems' mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The official website for the company is www.ramed.com. The company can be reached via phone at (760) 804-1648 or via email at jcain@lhai.com.

This page (NYSE:RMED) was last updated on 8/12/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.